Pheromones and the luteinizing hormone for inducing...

Details Pheromones and the luteinizing hormone for inducing... Pheromones and the luteinizing hormone for inducing...

2005-02-14

2010-12-07

Nickol, Gary B. (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C424S198100, C435S377000

Reexamination Certificate

active

07846898

ABSTRACT:
The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.

REFERENCES:
patent: 4703008 (1987-10-01), Lin
patent: 4902680 (1990-02-01), Aroonsakul
patent: 5023252 (1991-06-01), Hseih
patent: 5128242 (1992-07-01), Arimura et al.
patent: 5198542 (1993-03-01), Onda et al.
patent: 5208320 (1993-05-01), Kitada et al.
patent: 5268164 (1993-12-01), Kozarich et al.
patent: 5326860 (1994-07-01), Onda et al.
patent: 5441868 (1995-08-01), Lin
patent: 5505206 (1996-04-01), Walloch
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5506206 (1996-04-01), Kozarich et al.
patent: 5527527 (1996-06-01), Friden
patent: 5547935 (1996-08-01), Mullenbach et al.
patent: 5547993 (1996-08-01), Miki
patent: 5559143 (1996-09-01), McDonald et al.
patent: 5614184 (1997-03-01), Sytkowski et al.
patent: 5621080 (1997-04-01), Lin
patent: 5623050 (1997-04-01), Kitada et al.
patent: 5686416 (1997-11-01), Kozarich et al.
patent: 5723115 (1998-03-01), Serrero
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5801147 (1998-09-01), Kitada et al.
patent: 5833988 (1998-11-01), Friden
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5877169 (1999-03-01), Simpkins
patent: 5885574 (1999-03-01), Elliott
patent: 5955346 (1999-09-01), Wells et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6015555 (2000-01-01), Friden
patent: 6048971 (2000-04-01), Sytkowski et al.
patent: 6165783 (2000-12-01), Weiss et al.
patent: 6191106 (2001-02-01), Mullenbach et al.
patent: 6239105 (2001-05-01), Brewitt
patent: 6242563 (2001-06-01), Dong
patent: 6294346 (2001-09-01), Weiss
patent: 6329508 (2001-12-01), Friden
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6376218 (2002-04-01), Hsu et al.
patent: 6413952 (2002-07-01), Luengo et al.
patent: 6429186 (2002-08-01), Fuh et al.
patent: 6618698 (2003-09-01), Beausoleil et al.
patent: 7048934 (2006-05-01), Thompson et al.
patent: 7514072 (2009-04-01), Ehrenreich et al.
patent: 2002/0098178 (2002-07-01), Brand et al.
patent: 2003/0130197 (2003-07-01), Smith-Swintosky et al.
patent: 2003/0144203 (2003-07-01), Bowen
patent: 2004/0209812 (2004-10-01), Renzi et al.
patent: 2005/0009847 (2005-01-01), Bertilsson et al.
patent: 2006/0089309 (2006-04-01), Tucker et al.
patent: 2008/0286234 (2008-11-01), Eyink
patent: 2010/0028361 (2010-02-01), Smith et al.
patent: 2010/0047233 (2010-02-01), Smith et al.
patent: 2175992 (1995-05-01), None
patent: 2 353 553 (2000-06-01), None
patent: WO 93 01275 (1993-01-01), None
patent: WO 94 10292 (1994-05-01), None
patent: WO 95/13364 (1995-05-01), None
patent: WO9615226 (1996-05-01), None
patent: WO 96/40231 (1996-12-01), None
patent: WO 97/48729 (1997-12-01), None
patent: WO 99 15191 (1999-04-01), None
patent: WO 99 21966 (1999-05-01), None
patent: WO 00 05260 (2000-02-01), None
patent: WO 00 13650 (2000-03-01), None
patent: WO 01 28574 (2001-04-01), None
patent: WO0159074 (2001-08-01), None
patent: WO 02/085311 (2002-10-01), None
patent: WO 03/035475 (2003-05-01), None
patent: WO 03 040310 (2003-05-01), None
patent: WO2004011021 (2004-02-01), None
patent: WO2004011632 (2004-02-01), None
patent: WO2006037233 (2006-04-01), None
patent: WO2006037233 (2006-04-01), None
patent: WO2009057111 (2009-05-01), None
Curtis et al, Cell Cycle, 2(5): 428-430, 2003.
Arlotta et al, Annals of the New York Academy of Sciences, 991(1): 229-236, 2003.
Ostenfeld et al, Adv Tech Stand Neurosurg, 28: 3-89, 2003.
Bithell et al, (Clinical Science, 108: 13-22, 2003.
Parker et al, (Experimental Neurology, 194: 320-332, 2005.
Gage (Science, 287: 14331438, 2000.
Misra et al, J Pharm Pharmaceutic Sci,, 6(2): 252-273, 2003.
Al-Hader, A.A., et al. (1997). Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. Biology of Reproduction 56:501-507.
Al-Hader, A.A., et al. (1997). Neurons from fetal rat brain contains functions luteinizing hormone/chorionic gonadotropin receptors. Biology of Reproduction 56:1071-1076.
Karbanova, J., et al. (2004). Neural stem cells transplanted into intact brains as neurospheres form solid grafts composed of neurons, astrocytes and oligodendrocyte precursors. Biodmed. Papers 148(2):217-220.
Lei, Z.M., et al. (2001). Neural actions of luteinizing hormone and human chorionic gonadotropin. Seminars in Reproductive Medicine 19(1):103-109.
Reynolds, B.A., and Weiss, S. (1996). Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Developmental Biology 175:1-13.
Brown, J. et al. (2003). Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci. 17(10):2042-2046.
Dulac, C., and Torello, A.T. (2003). Molecular detection of pheromone signals in mammals: from genes to behaviour. Nat Rev Neurosci. 4(7):551-562.
Fernandez-Pol, J.A. (1985). Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. J. Biol. Chem. 260(8):5003-5011.
Fowler, C.D., et al. (2002). The effects of social environment on adult neurogenesis in the female prairie vole. J. Neurobiology 51(2):115-128.
Frisén, J., et al. (1998). Central nervous system stem cells in the embryo and adult. Cell Mol Life Sci. 54(9):935-945.
Gage, F.H. (2000). Mammalian neural stem cells. Science 287(5457):1433-1438.
Huhtaniemi, I. et al. (2002). Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Mol Cell Endocrinol. 187(1-2):49-56.
Johnson, D.L., and Jolliffe, L.K. (2000). Erythropoietin mimetic peptides and the future. Nephrol. Dial. Transplant. 15(9):1274-1277.
Kaushansky, K. (2001). Hematopoietic growth factor mimetics. Ann. N.Y. Acad. Sci. 938:131-138.
Kempermann, G., and Gage, F.H. (1999). Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal. Hippocampus. 9(3):321-332.
Kiyokawa, Y., et al. (2004). Modulatory role of testosterone in alarm pheromone release by male rats. Horm Behav. 45(2):122-127.
Luskin, M.B. (1993). Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron. 11(1):173-189.
Ma, W., et al. (1998). Role of the adrenal gland and adrenal-mediated chemosignals in suppression of estrus in the house mouse: the lee-boot effect revisited. Biol Reprod. 59(6):1317-1320.
Menezes, J.R., et al. (1995). The division of neuronal progenitor cells during migration in the neonatal mammalian forebrain. Mol Cell Neurosci. 6(6):496-508.
Mode, A., et al. (1996). The human growth hormone (hGH) antagonistG120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor. Endocrinology 137(2):447-454.
Moro, O., and Lerner, E.A. (1997). Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J. Biol. Chem. 272(2):966-970.
Morrison, S.J., et al. (1997). Regulatory mechanisms in stem cell biology. Cell 88:287-298.
Morshead, C.M., and van der Kooy, D. (1992). Postmitotic death is the fate of constitutively proliferating cells in the subependymal layer of the adult mouse brain. J Neurosci. 12(1):249-256.
Nilsson, M., et al. (1999). Enrich

Affiliated with

Also associated with

Rating

Pheromones and the luteinizing hormone for inducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pheromones and the luteinizing hormone for inducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pheromones and the luteinizing hormone for inducing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4192082